Nor does it reduce the risk of perinatal death or other major maternal or neonatal disorders in women in labor who have thick meconium staining of amniotic fluid.
Nor does it reduce the risk of perinatal death or other major maternal or neonatal disorders in women in labor who have thick meconium staining of amniotic fluid.
Researchers studied almost 2,000 women from 56 centers in 13 countries. The women were enrolled during labor if they had thick meconium staining of amniotic fluid, a singleton fetus of at least 36 weeks' gestation presenting cephalically, ruptured membranes, a cervix dilated between 2 and 7 cm, and no indication for urgent delivery.
Perinatal death, moderate or severe meconium aspiration syndrome, or both occurred in 4.5% of the infants born to women in the amnioinfusion group, compared to 3.5% of those born to women in the control group (RR 1.26; 95% CI; 0.82–1.95). Rates of perinatal death and cesarean delivery were similar in both groups; five deaths occurred in each group, and 31.8% of the amnioinfusion group versus 29% of the control group required C-sections.
An editorial in the same issue of the New England Journal of Medicine suggests that the failure of the procedure to prevent meconium aspiration syndrome may be the result of the fact that most infants in whom the syndrome develops have meconium in the tracheobronchial tree before presentation in labor, and dilution of meconium in amniotic fluid cannot address this problem.
Until we better understand the factors that influence when a fetal colon will pass meconium, the editorial concluded that the best way to reduce the incidence of meconium aspiration syndrome is to keep the rate of postterm delivery to a minimum.
Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 2005;353:909-917.
Ross MG. Meconium aspiration syndrome-more than intrapartum meconium. N Engl J Med. 2005;353:946-948.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More